Identification and development of a novel risk model based on cuproptosis-associated RNA methylation regulators for predicting prognosis and characterizing immune status in hepatocellular carcinoma.
Duguang LiZhaoqi ShiXiaolong LiuShengxi JinPeng ChenYiyin ZhangGuoqiao ChenXiaoxiao FanJing YangHui LinPublished in: Hepatology international (2023)
Overall, our predictive signature displayed potential value in the prediction of overall survival of HCC patients and might provide valuable clues for personalized therapies.